Skip to main content
OpenTrials

Clinical trial condition

Choroidal Neovascularization

Explore clinical trials studying Choroidal Neovascularization. Study availability and eligibility vary by location and protocol.

150 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Choroidal Neovascularization trial results

Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details
Completed

A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

NCT04239027

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 40 locations
View Trial Details
Completed

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

NCT01436864

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • First Affiliated Hospital of Fujian Medical College Fuzhou, Fujian, China
  • Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong Shantou, Guangdong, China
  • People's Hospital of Wuhan University Wuhan, Hubei, China
  • Wuhan General Hospital of Guangzhou Military Command Wuhan, Hubei, China
View Trial Details
Completed

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

NCT01716026

Conditions
Choroid Diseases, Choroidal Neovascularization, Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia, +6 more
Locations
  • CHUS - Fundacion IDICHUS Santiago de Compostela, La Coruña, Spain
  • Clinica Universitaria de Navarra Pamplona, Navarre, Spain
  • Complejo Hospitalario de Albacete Albacete, Spain
  • Hospital Clinico Universitario San Carlos Madrid, Spain
View Trial Details

Related conditions